Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).

Transfusion. 2013 Apr;53(4):704-9. doi: 10.1111/j.1537-2995.2012.03796.x. Epub 2012 Jul 13.

2.

Alloimmunization in sickle cell anemia in the era of extended red cell typing.

O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA.

Pediatr Blood Cancer. 2013 Sep;60(9):1487-91. doi: 10.1002/pbc.24530. Epub 2013 Mar 18.

PMID:
23508932
3.

Red blood cell alloimmunization: lessons from sickle cell disease.

Treml A, King KE.

Transfusion. 2013 Apr;53(4):692-5. doi: 10.1111/trf.12146. No abstract available.

PMID:
23565994
4.

Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom.

Mijovic A, Perera IG, Thein SL.

Transfusion. 2013 Dec;53(12):3279-80. doi: 10.1111/trf.12382. No abstract available.

PMID:
24320815
5.

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.

Pediatrics. 2003 Jun;111(6 Pt 1):e661-5.

PMID:
12777582
6.
7.

Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.

Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA.

Transfusion. 2014 Aug;54(8):2034-44. doi: 10.1111/trf.12585. Epub 2014 Feb 27.

8.

High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM.

Blood. 2013 Aug 8;122(6):1062-71. doi: 10.1182/blood-2013-03-490623. Epub 2013 May 30.

9.

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.

Transfusion. 2002 Jan;42(1):37-43. Review.

PMID:
11896310
10.

Transfusion therapy for sickle cell disease: a balancing act.

Chou ST.

Hematology Am Soc Hematol Educ Program. 2013;2013:439-46. doi: 10.1182/asheducation-2013.1.439. Review.

PMID:
24319217
11.

Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion.

Roberts DO, Covert B, Lindsey T, Edwards V, McLaughlin L, Theus J, Wray RJ, Jupka K, Baker D, Robbins M, DeBaun MR.

Immunohematology. 2012;28(1):7-12.

PMID:
22646143
12.
14.

Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.

Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A.

Transfusion. 2013 Apr;53(4):710-5. doi: 10.1111/j.1537-2995.2012.03819.x. Epub 2012 Jul 31.

PMID:
22845746
15.

Red cell alloantibodies in patients with haemoglobinopathies.

Hmida S, Mojaat N, Maamar M, Bejaoui M, Mediouni M, Boukef K.

Nouv Rev Fr Hematol. 1994 Oct;36(5):363-6.

PMID:
7892131
16.

Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.

Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA.

Transfusion. 2014 Jan;54(1):86-97. doi: 10.1111/trf.12250. Epub 2013 May 21.

17.

A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease.

Harm SK, Yazer MH, Monis GF, Triulzi DJ, Aubuchon JP, Delaney M.

Am J Clin Pathol. 2014 Feb;141(2):256-61. doi: 10.1309/AJCP47QAAXTOZEKJ.

PMID:
24436274
18.

Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).

Lasalle-Williams M, Nuss R, Le T, Cole L, Hassell K, Murphy JR, Ambruso DR.

Transfusion. 2011 Aug;51(8):1732-9. doi: 10.1111/j.1537-2995.2010.03045.x. Epub 2011 Feb 18.

PMID:
21332724
19.

Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.

Sins JW, Biemond BJ, van den Bersselaar SM, Heijboer H, Rijneveld AW, Cnossen MH, Kerkhoffs JL, van Meurs AH, von Ronnen FB, Zalpuri S, de Rijke YB, Ellen van der Schoot C, de Haas M, van der Bom JG, Fijnvandraat K.

Am J Hematol. 2016 Aug;91(8):763-9. doi: 10.1002/ajh.24397. Epub 2016 May 24.

20.

HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.

McPherson ME, Anderson AR, Castillejo MI, Hillyer CD, Bray RA, Gebel HM, Josephson CD.

Pediatr Blood Cancer. 2010 Apr;54(4):552-8. doi: 10.1002/pbc.22327.

Supplemental Content

Support Center